What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $6.57B, above the global median of $1.14B
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
8.71TKRW6.57B · vs all stocks (USD)
Revenue (TTM)
1.51TKRW1.14B · vs all stocks (USD)
Profit Margin
33.90%vs Biotechnology peers
52-Week Change
-20.07%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
8.71TKRW6.57B · vs all stocks (USD)
Enterprise Value
9.00TKRW6.79B · vs all stocks (USD)
Forward P/E
25.93xvs Biotechnology peers
Price to Sales (TTM)
5.76xvs Biotechnology peers
Enterprise to Revenue
5.96xvs Biotechnology peers
Profit Margin
33.90%vs Biotechnology peers
Operating Margin
14.99%vs Biotechnology peers
Revenue (TTM)
1.51TKRW1.14B · vs all stocks (USD)
Revenue per Share (TTM)
60.76KKRWUpdated Oct 19, 2026Gross Profit (TTM)
546.02BKRW411.89M · vs all stocks (USD)
EBITDA (TTM)
26.82BKRW20.23M · vs all stocks (USD)
Net Income (TTM)
511.88BKRW386.14M · vs all stocks (USD)
Operating Cash Flow (TTM)
-622.47BKRW-469.57M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
0.00KRWvs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Biotechnology peers
Shares Outstanding
24.84MSharesUpdated Oct 19, 2026Float Shares
6.35MSharesUpdated Oct 19, 2026% Held by Insiders
74.29%vs all stocks
% Held by Institutions
10.16%vs all stocks
Total Cash (MRQ)
185.98BKRW140.30M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.49KKRWUpdated Oct 19, 2026Total Debt (MRQ)
481.18BKRW362.99M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0790xvs Biotechnology peers
Current Ratio (MRQ)
1.36xvs Biotechnology peers
52-Week Low
297.50KKRWUpdated Oct 19, 202652-Week High
773.00KKRWUpdated Oct 19, 202652-Week Change
-20.07%vs all stocks
50-Day MA
359.29KKRWUpdated Oct 19, 2026200-Day MA
485.18KKRWUpdated Oct 19, 2026Avg 10-Day Volume
37.15KSharesUpdated Oct 19, 2026Avg 30-Day Volume
37.07KSharesUpdated Oct 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 386,141,008.5Operating Cash Flow (USD, TTM): -469,566,398.616
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $6.57B, above the global median of $1.14BNotable
Market cap (USD): 6,566,964,595.453Global Median: 1,137,180,293.291
Revenue is $1.14B, above the global median of $566.17MNotable
Revenue (USD): 1,139,189,026.747Global Median: 566,172,992
Companies that share the same coordination system — how they create, deliver, or capture value.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lantheus Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Iovance Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
H. Lundbeck A/S
Tier 1ProductionApproval-Gated PipelineRuleFlow
Huadong Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Rhythm Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Oruka Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Demant A/S
Tier 1ProductionApproval-Gated PipelineFlowRule
Shenzhen New Industries Biomedical Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Glenmark Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule